PSCR OTC
Proto Script Pharmaceutical Corp.
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.0%
5Y: -97.1%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$44K
+15.8% ▲
Capital Expenditures
$15K
-151.1% ▼
Free Cash Flow
$29K
-9.8% ▼
Dividends Paid
$60K
+34.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6K
+74.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $0 | -$32K | -$38K | -$145K | -$7M |
| Depreciation & Amort. | $0 | $0 | $0 | $76K | $5K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $9K | $407 | $5K | $55K | $357K |
| Other Non-Cash Items | -$33K | $0 | $1K | $52K | $7M |
| Operating Cash Flow | -$24K | -$32K | -$33K | $38K | $44K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$6K | -$15K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$1K | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$1K | $0 | -$6K | -$15K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $15K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$90K | -$60K |
| Other Financing | $24K | $78K | $74K | $36K | $10K |
| Financing Cash Flow | $24K | $78K | $0 | -$54K | -$34K |
| Net Change in Cash | $570 | $45K | -$33K | -$22K | -$6K |
| Cash End of Period | $1K | $46K | $14K | $9K | $4K |
| Free Cash Flow | -$24K | -$32K | -$33K | $32K | $29K |